[Form 4] NovoCure Ltd Insider Trading Activity
Rhea-AI Filing Summary
NovoCure Ltd Chief Operating Officer Paravasthu Mukund reported a combination of equity grants and share sales. On March 3, 2026, he received 45,112 Ordinary Shares as a grant, described as restricted share units that vest in equal parts on the first, second and third anniversaries of the grant date, subject to continued employment. On the same date, he was granted stock options over 7,518 Ordinary Shares and 58,488 Ordinary Shares, with these options scheduled to vest in equal parts on the first, second, third and fourth anniversaries of the grant date, also conditioned on continued employment.
Subsequently, Mukund executed open-market sales of 5,377 Ordinary Shares on March 4, 2026 at a weighted average price of $13.3054 per share and 43,246 Ordinary Shares on March 5, 2026 at a weighted average price of $13.7740 per share. A footnote states that the number of shares sold was required to cover tax withholding obligations related to the vesting of restricted stock units and was mandated by NovoCure's award agreement as a "sell to cover" transaction, rather than a discretionary trade. After the March 5 sale, Mukund directly held 72,832 Ordinary Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 43,246 | $13.774 | $596K |
| Sale | Ordinary Shares | 5,377 | $13.3054 | $72K |
| Grant/Award | Stock Option (Right to Buy) | 7,518 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 58,488 | $0.00 | -- |
| Grant/Award | Ordinary Shares | 45,112 | $0.00 | -- |
Footnotes (1)
- Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $13.74 USD to $14.07 USD; the price reported above reflects the weighted average sale price. Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.
